Top Markets
#1 Siren Siren +35.00%
#2 TDCCP TDCCP +20.44%
#3 aelf aelf +17.29%
#4 DAPPOS DAPPOS +14.71%
#5 Status Status +7.72%
#6 Tutorial Tutorial +7.24%
#7 DeXe DeXe +6.91%
#8 GRVT Token GRVT Token +6.69%
#9 HOME HOME +6.45%
#10 OpenGradient OpenGradient +6.28%
Coin of the day
Siren Siren
Settings
Language
ENGLISH
Currency
USD
Theme
Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

Sinopep-Allsino Bio Pharmaceutical Co.,Ltd.

688076
Rank in Stocks #8443
Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company,... Jiangsu Sinopep-Allsino Biopharmaceutical Co., Ltd., a biomedical company, engages in the research and development, production, and sale of peptides, oligonucleotides, and small molecule drugs in China. The company offers Peptide CDMO Services,GMP oligo, full-time equivalent, discovery, generic APIs, and formulation services. It is also involved in professional technical services. The company was founded in 2009 and is headquartered in Hangzhou, China.
Share Price
$3.99
Last synced: 2026-08-28
Market Cap
$1.26B
Change (1 day)
-0.04%
Change (1 year)
-33.48%
Country
CN
Trade Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)

Category

Healthcare
P/S ratio for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. (688076)
P/S ratio as of 2026 TTM: 0
According to Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. latest financial reports and stock price the company's current price-to-sales ratio (TTM) is 0. At the end of 2026 the company had a P/S ratio of 0.
P/S ratio history for Sinopep-Allsino Bio Pharmaceutical Co.,Ltd. from 2026 to 2026
P/S ratio at the end of each year
Year P/S Ratio Change
Not enough data for the provided dates.
P/S ratio for similar companies or competitors
Company P/S Ratio P/S Ratio Difference Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
10.17 -
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
10.13 -
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
2.95 -
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
11.28 -
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
- -
CH